Dr  Peter  Bogaty  

PUBLICATIONS

1. Lambert L, Blais C, Hamel D, Brown K, Rinfret S, Cartier M, Giguère M, Caroll C, Beauchamp Christiane, Bogaty P. Evaluation of care and surveillance of cardiovascular disease: Can we trust medico-administrative hospital data? Can J Cardiol 2012 in press

2. Bogaty P, Filion K, Brophy JM. Routine Invasive Management After Fibrinolysis in Patients with ST-Elevation Myocardial Infarction: A Critical Review. BMC Cardiovasc Disord. 2011;11:34.

3. Hamelin BA, Zakrzewski-Jakubiak M, Robitaille MN, Bogaty P, Labbé L, Turgeon J.

Increased risk of myocardial infarction associated with angiotensin-converting enzyme gene polymorphism is age dependent. J Clin Pharmacol 2011; 51:1286-92.

4. St Germain CG, Bogaty P, Boyer L, Hanley J, Engert JC, Brophy JM. Genetic

polymorphisms and the cardiovascular risk of non-steroidal anti-inflammatory drugs. Am J Cardiol 2010;105:1740-5.

5. Lambert L, Brown K, Segal E, Brophy J, Rodes-Cabau J, Bogaty P. Association between timeliness of reperfusion therapy and clinical outcomes in ST-elevation myocardial infarction. JAMA 2010;303:2148-55.

6. Cardinal H, Brophy JM, Bogaty P, Joseph L, Hébert MJ, Boyer L, Madore F. Usefulness of Fas levels for improving diagnostic accuracy and prognosis for acute coronary syndromes. Am J Cardiol 2010; 105:797-803.

7. Noël M, Jobin J, Marcoux A, Poirier P, Dagenais GR, Bogaty P. Comparison of Myocardial Ischemia on the Ergocycle versus the treadmill in patients with coronary heart disease. Am J Cardiol 2010; 105:633-9.

8. Cardinal H, Bogaty P, Madore F, Boyer L, Joseph L, Brophy JM. Therapeutic Management in Patients with Renal Failure who Experience an Acute Coronary Syndrome. Clin J Am Soc Nephrol 2009;5:87-94.

9. Bogaty P, Brophy JM. Letter to the Editor in response to Cantor WJ et al. Routine Early Angioplasty after Fibrinolysis for Acute Myocardial Infarction. N Eng J Med 2009;361:1508.

10. Bogaty P. Duration of Symptoms Is Not Always the Key Modulator of the Choice of

Reperfusion for ST-Elevation Myocardial Infarction. Circulation 2009;119:1304-10.

11. Bogaty P. Response to Armstrong P et al. Duration of Symptoms Is the Key Modulator of the Choice of Reperfusion for Myocardial Infarction. Circulation 2009;119:1303.

12. Ferland A, Brassard P, Lemieux S, Bergeron J, Bogaty P, Bertrand F, Simard S, Poirier P.

Impact of High-fat/low-carbohydrate, High-, Low-glycaemic Index or low-caloric Meals on Glucoregulation during Aerobic Exercise in Type 2 Diabetes. Diabet Med 2009;26:589-95.

13. Dagenais GR, St-Pierre A, Gilbert P, Lamarche B, Després JP, Bernard PM, Bogaty P.

Comparison of prognosis for men with type 2 diabetes mellitus and men with cardiovascular disease. CMAJ 2009;180:40-7.

14. Bogaty P. Little predictive value in measuring CRP levels in ACS patients, new study

suggests. 9 Juin 2008 http://www.theheart.org/article/873105.do Heart Org 2008

Dr Peter Bogaty

Page 2 of 24

15. Rodés-Cabau J, Noël M, Marrero A, Rivest D, Mackey A, Houde C, Bédard E, Larose E,

Verreault S, Peticlerc M, Pibarot P, Bogaty P, Bertrand OF. Atherosclerotic Burden findings in young cryptogenic stroke patiens with and without foramen ovale. Stroke 2008;40:419-25. Epub 2008 Dec 18.

16. Rodés-Cabau J, Deblois J, Bertrand OF, Mohammadi S, Courtis J, Larose E, Dagenais F,

Déry JP, Mathieu P, Rousseau M, Barbeau G, Baillot R, Gleeton O, Perron J, Nguyen CM, Roy L, Doyle D, De Larochellière R, Bogaty P, Voisine P. Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians. Circulation 2008;118:2326-9. Epub 2008 Nov 24.

17. Bogaty P, Simard S, Dagenais GR, Brophy JM. Acute Coronary Syndromes: “To CRP or not

to CRP?" J Am Coll Cardiol 2008;52:1500; author reply 1500-1. 18. Bogaty P, Boyer L, Simard S, Dauwe F, Dupuis R, Verret B, Huynh T, Roux R, d'Astous M,

Bertrand F, Dagenais GR, Brophy J. Clinical utility of C-reactive protein measured at admission, hospital discharge or one month later to predict outcome in patients with acute coronary disease: The RISCA Study. J Am Coll Cardiol 2008;51:2339-46.

19. Bogaty P, Poirier P, Boyer L, Simard S, Morin J, Dagenais GR. Effects of Exogenous

Metabolic Substrate Modulation on Exercise-Induced Myocardial Ischemia. Am Heart J 2008;156:790-796. Epub 2008 Aug 9.766

20. Bogaty P , Brophy JM. Letter to the editor in response to Citywide Protocol for Primary PCI

in ST-Segment Elevation Myocardial Infarction, Le May et al. N Eng J Med 2008;358:1751. 21. Bogaty P, Noël M. Poirier P, Dagenais R. Can prolonged exercise-induced myocardial

ischaemia be innocuous? reply. Eur Heart J. 2008;29:139-40. 22. Bogaty P, Boothroyd L, Lambert L, Lance JM, Paquette D. Enjeux organisationnels

préhospitaliers, intra et interhospitaliers et économiques pour la prise en charge avec l'infarctus aigu du myocarde avec élévation du segment ST (IAMEST). Agence d'évaluations des technologies et des modes d'intervention en santé 2007. http://www.aetmis.gouv.qc.ca/site/34.1064.0.0.1.0.phtml

23. Lambert L, Bogaty P, Brophy J, Boothroyd L. La pratique d'interventions coronariennes

percutanées dans les hôpitaux sans service de chirurgie cardiaque sur place: revue des lignes directrices et analyse des donnée québecoises de 1999-2004. Agence d'évaluations des technologies et des modes d'intervention en santé 2007. http://www.aetmis.gouv.qc.ca/site/phpwcms_filestorage/c50a9b653ab55beeda8d2f11a01285c6.pdf

24. Bogaty P, Noël M, Poirier P, Dagenais GR. Can prolonged exercise-induced myocardial

ischaemia be innocuous? Author reply. Eur Heart J 2007;29:139-40. 25. Dagenais G, Philippon F, Després JP, Dumesnil JG, Cartier P, Bogaty P, Lemieux M,

Moisan A. The Quebec Heart Institute: 50 years of excellence in cardiology. Can J Cardiol 2007;23:Suppl B:5B-8B.

26. Brassard P, Legault S, Garneau C, Bogaty P, Dumesnil JG, Poirier P. Normalization of

diastolic dysfunction in type 2 diabetics after exercise training. Med Sci Sports Exerc 2007;39:1896-901.

Dr Peter Bogaty

Page 3 of 24

27. Noël M, Jobin J, Marcoux A, Poirier P, Dagenais GR, Bogaty P. Can Prolonged Exercise-Induced Myocardial Ischemia Be Innocuous? Eur Heart J ;28:1559-65.

28. Hachicha Z, Dumesnil JG, Bogaty P, Pibarot P. Paradoxical low flow, low gradient severe

aortic stenosis despite preserved ejection fraction reflects more severe disease and poorer prognosis: implications for diagnosis and treatment. Circulation 2007;115:2856-64.

29. Noël M, Jobin J, Poirier P, Dagenais GR, Bogaty P. Effect of a ramp versus standard Bruce

exercise test protocol on exercise-induces myocardial ischemia. Am J Cardiol 2007;99:921-4.

30. Beanlands RS, Chow BJ, Dick A, Friedrich MG, Gulenchyn KY, Kiess M, Leong-Poi H,

Miller RM, Nichol G, Freeman, Bogaty P, Honos G, Hudon G. Wisenberg G, Van Berkom J, Williams K, Yoshinaga K, Graham ; on behalf of the Canadian Cardiovascular Society, the Canadian Association of Radiologist, the Canadian association of Nuclear Medicine, The Canadian Nuclear Cardiology Society and the Canadian Society of Cardiac Magnetic Resonance. CCS/CAR/CANM/CNCS/CanSCMR joint position statement on advanced noninvasive cardiac imaging using positron emission tomography, magnetic resonance imaging and multidetector computed tomographic angiography in the diagnosis and evaluation of ischemic heart disease--executive summary. Can J Cardiol2007;23:107-119.

31. Bogaty P, Brophy JM. Acute ischemic heart disease and interventional cardiology: A time for

a pause. BMC Medicine 2006 ;4 :25. 32. Brassard P, Ferland A, Bogaty P, Desmeules M, Jobin J and Poirier P: Influence of glycemic

control on pulmonary function and heart rate in response to exercise in subjects with type 2 diabetes mellitus Metabolism 2006 ;55:1532-37.

33. Méthot J, Hamelin BA, Arsenault M, Bogaty P, Plante S and Poirier P: The ACE-DD

genotype is associated with endothelial dysfunction in postmenopausal women. Menopause 2006;13:959-66.

34. Bourgault C, Bergeron S, Bogaty P, Poirier P. A most unusual acute coronary syndrome.

Can J Cardiol 2006;22:1-4. 35. Méthot J, Hamelin BA, Bogaty P, Arsenault M, Plante S, Poirier P. ACE-DD genotype is

associated with the occurrence of acute coronary syndrome in postmenopausal women. Int J Cardiol 2005;105:308-14.

36. Armstrong PW, Bogaty P, Buller CE, O’neill BJ. Guidelines for STEMI. CMAJ

2005;172:1426. 37. Bogaty P, Brophy JM. Numbers needed to treat (needlessly?). Lancet 2005;365: 1307-08. 38. Bogaty P, Brophy J. GRACIA : Implications for clinical practice. Lancet 2005;365:381. 39. Bogaty P, Brophy J, Boyer L, Simard S, Bertrand F, Dagenais GR. Fluctuating inflammatory

markers in patients with stable ischemic heart disease. Arch Int Med 2005 ;165 :221-226. 40. Methot J, Hamelin B, Bogaty P, Arsenault M, Plante S, Poirier P. Does hormonal status

influence the clinical presentation of acute coronary syndromes in women? J Womens Health 2004;13:695-702.

41. Bogaty P, Buller CE, Dorian P, O’Neill BJ, Armstrong PW. Reperfusion in acute ST elevation

myocardial infarction : Application of new ST-elevation myocardial infarction (STEMI) guidelines. CMAJ 2004 ;171 :1039-1041.

Dr Peter Bogaty

Page 4 of 24

42. Dorian P, Bogaty P, Buller CE, O ‘Neill BJ, Armstrong PW. Disturbances of cardiac rhythm

after ST-elevation myocardial infarction : Application of new ST-elevation myocardial infarction (STEMI) guidelines. CMAJ 2004 ;171 :1042-44.

43. Brophy JM, Bogaty P. Primary angioplasty and thrombolysis are both reasonable options in

acute myocardial infarction. Ann Int Med 2004;141:292-297. 44. Bogaty P, Brophy J, Boyer L, Simard S, Bertrand F, Noel M, Dagenais GR. Impact of

prolonged cyclooxygenase-2 inhibition on inflammatory markers and endothelial function in patients with ischemic heart disease and raised C-reactive protein: a randomized placebo-controlled study. Circulation 2004;110:934-939.

45. Armstrong P, Bogaty P, Buller C, Dorian P, O'Neill B. The 2004 ACC/AHA Guidelines: A

Perspective and Adaptation for Canada by the Canadian Cardiovascular Society Working Group. Can J Cardiol 2004;20:1075-1079.

46. Bogaty P, Brophy J. Primary angioplasty or thrombolysis? A topical parable. BMJ

2004;328:1257-1258. 47. Fitchett D, Rockwood K, Chan BT, Schultz S, Bogaty P, Gillis A, Arnold M, Miller F, Graham

MM, Ghali WA, Cartier R. Chow CM, Grymonpre R, Ogilvie R, Rochon P, Niznick J, Grover S, Kavanah T, Triscott J, Dafoe W, McCartney N, Rodney P, Howlett J, Chockalingam A, Dagenais G, Dalziel W, Fodor G, Goodman S, Kerr C, Power B. Murphy K. Canadian Cardiovascular Society Consensus Conference 2002: Management of heart disease in the elderly patient. Can J Cardiol 2004;20(suppl A):7A-16A.

48. Bogaty P, Dagenais GR, Poirier P, Boyer L, Auclair L, Pépin G, Jobin J, Arsenault M. Effect

of Atorvastatin on exercise-induced myocardial ischemia in patients with stable angina pectoris. Am J Cardiol 2003;92:1192-1195.

49. Bogaty P, Brophy J. Increasing burden of treatment in the acute coronary syndromes : Is it

justified? Lancet 2003;361:1813-1816. 50. Dagenais GR, Auger P, Bogaty P, Gerstein H, Lonn E, Yi Q, Yusuf S; HOPE Study

Investigators.Increased occurrence of diabetes in people with ischemic cardiovascular disease and general and abdominal obesity. Can J Cardiol. 2003;19:1387-1391.

51. Bogaty P, Poirier P, Dagenais GR, Boyer L, Jobin J. What induces warm-up ischemia /

Angina Phenomenon: exercise or myocardial ischemia? Circulation 2003;107:1858-1863. 52. Hamelin BA, Methot J, Arsenault M, Pilote S, Poirier P, Plante S, Bogaty P. Influence of the

menstrual cycle on the timing of acute coronary events in young women with coronary artery disease. Am J Med 2003;114:599-602.

53. Poirier P, Bogaty P, Philippon F, Garneau C, Fortin C, Dumesnil JG. Preclinical diabetic

cardiomyopathy : Relation of left ventricular diastolic dysfunction to cardiac automatic neuropathy in uncomplicated well-controlled men with type 2 diabetes. Metabolism 2003;52:1056-1061.

54. Morin J, Bogaty PM, Roy L, Poirier P. Trauma-induced occlusion of the left anterior

descending artery following a snowmobile accident in a man without prior coronary artery disease. Can J Cardiol 2003;5:565-568.

55. Bogaty P, Boyer L, Rousseau L, Arsenault M. Is anteroseptal myocardial infarction an

appropriate term? Am J Med 2002;113:37-41.

Dr Peter Bogaty

Page 5 of 24

56. Bogaty P, Muré P, Dumesnil JG. New Insights into Diastolic Dysfunction as the Cause of

Acute Left-Sided Heart Failure Associated With Systemic Hypertension and/or Coronary Artery Disease. Am J Cardiol 2002;89:341-345.

57. Cantin B, Despres JP, Lamarche B, Moorjani S, Lupien PJ, Bogaty P, Bergeron J, Dagenais

GR. Association of fibrinogen and lipoprotein(a) as a coronary heart disease risk factor in men (The Quebec Cardiovascular Study). Am J Cardiol 2002;89:662-666.

58. Bergeron S, Demers C, Bogaty P, Poirier P. The endocarditis that was not: an unsual case

of heparin-induced thrombocytopenia with unusual complications. Can J Cardiol 2001;17:1180-1182.

59. Huynh T, Théroux P, Bogaty P, Nasmith J, Solymoss S. Aspirin, warfarin or the combination

for the secondary prevention of coronary events in patients with acute coronary syndromes and prior coronary artery bypass surgery. Circulation 2001;103:3069-3074.

60. Bogaty P, Poirier P, Simard S, Solymoss S, Boyer L, Dagenais GR. Biological profiles in

subjects with recurrent acute coronary events compared to longstanding stable angina Circulation 2001;103:3062-3068.

61. Lemieux I, Pascot A, Prud'homme D, Alméras N, Bogaty P, Nadeau A, Bergeron J, Després,

J-P. Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arterioscler Thromb Vasc Biol 2001;21:961-967.

62. Bogaty P. Myocardial Infarction After Dog Bite. Circulation 2001;103:e95-a. 63. Porier P, Bogaty P, Garneau C, Marois L, Dumesnil J-G. Diastolic dysfunction in

normotensive men with well-controlled type 2 diabetes. Diabetes Care 2001;24:5-10. 64. Bogaty P, Dumont S, O'Hara GE, Boyer L, Auclair L, Jobin J, Boudreault JR. Randomized

trial of a non-invasive strategy to reduce hospital stay for patients with low-risk myocardial infarction. J Am Coll Cardiol 2001;37:1289-1296.

65. Bogaty P, Kingma J, Guimond J, Poirier P, Boyer L, Charbonneau L, Dagenais GR.

Myocardial perfusion imaging findings and the role of adenosine in the warm-up angina phenomenon. J Am Coll Cardiol 2001;37:463-469.

66. Kingma JG Jr, Plante S, Bogaty P . Platelet GPIIb/IIIa blockade reduces infarct size in a

canine model of ischemia-reperfusion. J Am Coll Cardiol 2000;36:2317-2324. 67. Poirier P, Garneau C, Bogaty P, Nadeau A, Marois L, Brochu C, Gingras C, Fortin C, Jobin

J, Dumsenil J-G. Impact of left ventricular diastolic dysfunction on maximal treadmill performance in normotensive subjects with well-controlled type 2 diabetes mellitus. Am J Cardiol 2000;85:473-477.

68. Bogaty P, Dagenais GR. Revascularization after myocardial infarction. Circulation

1999;99:1272-1273. 69. Bogaty P, Kingma JG, Robitaille N-M, Plante S, Simard S, Charbonneau L, Dumesnil JG.

Attenuation of myocardial ischemia with repeated exercise in subjects with chronic stable angina: relation to myocardial contractility, intensity of exercise, and the ATP-sensitive potassium channel. J Am Coll Cardiol 1998;32:1665-1671.

Dr Peter Bogaty

Page 6 of 24

70. Bogaty P, Robitaille N-M, Solymoss S, Boyer L, Auger D, Labbé L, Simard S, Rail J, Genest Jr J, Turgeon J. Atherogenic, hemostatic and other potential risk markers in subjects with previous isolated myocardial infarction compared to longstanding uncomplicated stable angina. Am Heart J 1998;136:884-893.

71. Tanser P, Baird M, Bogaty P, Bernstein V, Cox J, Cujec B, Finnie K, Langer A, McCans J,

McKelvie R, Miller A, Parker JO, Rose B, Sestier F, Warnica W. Canadian Cardiovascular Society 1997 Consensus Conference on the Evaluation and Management of Chronic Ischemic Heart Disease. Can J Cardiol 1998;14 (Suppl C):1C-24C.

72. Brophy JM, Diodati JG, Bogaty P, Théroux P. The delay to thrombolysis: An analysis of

patient and hospital characteristics. CMAJ 1998;158:475-480. 73. Cairns J, Théroux P, Armstrong P, Bogaty P, Kells C, Thompson C, Warnica W. Unstable

angina: report from a Canadian Expert Roundtable. Can J Cardiol 1996;12:1279-92 (also appears in ACC Current Journal Review July/August 1998 pp 43-8).

74. Miyagashima R, Plante S, Abel JG, Bogaty P. Unstable Angina and non-Q-wave infarction.

Can J Cardiol 1997;13 (suppl D):30D-39D. 75. Bogaty P, Guimond J, Robitaille N-M, Rousseau L, Simard S, Rouleau JR, Dagenais GR. A

reappraisal of exercise electrocardiographic indices of the severity of ischemic heart disease: angiographic and scintigraphic correlates. J Am Coll Cardiol 1997;29:1497-1504.

76. çKingma JG Jr, Bogaty P. Reperfusion injury: fact, fiction or simply unresolvable? J Thromb

Thrombolysis 1997;4:145-147. 77. Cairns J, Theroux P, Armstrong P, Bogaty P, Kells C, Thompson C, Warnica W. Unstable

Angina—report from a Canadian expert rountable. Can J Cardiol 1996;12:1279-1292. 78. Dagenais GR, Cantin B, Dagenais F, Lupien PJ, Robitaille N-M, Bogaty P. Importance of

outside hospital mortality as a first acute ischemic heart event: The Quebec Cardiovascular Study. Can J Cardiol 1996;12:914-918.

79. Bogaty P, Hackett D, Davies G, Maseri A. Vasoreactivity at culprit lesions (Letters to the

Editor) Circulation 1995;91:563-564. 80. Bogaty P, Gavrielides S, Mure P, Gaspardone A, Maseri A. The duration and magnitude of

ST segment depression during exercise and recovery: A symmetrical relationship. Am Heart J 1995;12:666-671.

81. Bogaty P, Hackett D, Davies G, Maseri A. Vasoreactivity of the culprit lesion in unstable

angina. Circulation 1994;90:5-11. 82. Bogaty P, Brecker SJ, White SE, Stevenson RN, El-Tamimi H, Balcon R, Maseri A. A

comparison of coronary angiographic findings at acute and chronic first presentation of ischemic heart disease. Circulation 1993;87:1938-1946.

83. Tousoulis D, Kaski JC, Bogaty P, Crea F, Gavrielides S, Galassi A, Maseri A. Reactivity of

proximal and distal angiographically normal and stenotic coronary segments in chronic stable angina. Am J Cardiol 1991; 67:1195-200.

84. Dagenais GR, Rouleau JR, Bogaty P. Prognosis for patients with painless strongly positive

exercise ECGs. J Angina Silent Ischemia 1990; 5:4-7.

Dr Peter Bogaty

Page 7 of 24

85. Bogaty P, Dagenais GR, Cantin B, Alain P, Rouleau JR. Prognosis in patients with a strongly positive exercise electrocardiogram. Am J Cardiol 1989;64:1284-8.

86. Bogaty P, Waters DD. Circadian patterns in coronary disease: the mournefulness of

morning. Can J Cardiol 1988;4:5-11.

BOOK CHAPTERS 1. Brophy JM, Bogaty P, Hot Topic: Cyclooxygenase-2 inhibition and coronary risk.

Harrisons’online updates http://www.accessmedicine.com 2005 Related To: Chapter 225. Prevention and Treatment of Atherosclerosis; Chapter 226. Ischemic Heart Disease; Chapter 312. Osteoarthritis.

2. Dagenais GR, Bogaty P. Impacts of ACE inhibitors on diseases of the heart, kidneys, and

brain. In Drug Advances, Jean Gray, ed., REMEDICA Publishing Ltd (London, UK) 2003, Chapter 5, pp. 113-135.

3. Bogaty P, Waters DD. Circadian patterns in heart disease. Chronopharmacology: Cellular

and Biochemical Interactions, edit. Bjorn Lemmer. Marcel Dekker Inc., New York and Basel 1989. Chapter 22, pp 509-24.

Dr Peter Bogaty

Page 8 of 24

ABSTRACTS

1. Bogaty P, Xiao Y, Nasmith J, Segal E, Kouz S, Rinfret S, L’Allier P, Ross d, Vanasse A

Maire S, Lambert L. Under the Radar: Deaths From ST-Elevation Myocardial Infarction That Do Not Appear in Registries. Circulation 2011;124(Suppl A):1280.

2. Lambert L, Sas G, Boothroyd LJ, Guertin JR, Carrier M, Cecere R, Charbonneau E, Ducharme A, Bogaty P. A New Model For Evalating Emerging Technologies: The Example Of Ventricular Assist Devices. CCS 2011; Can J Cardiol 2011;27(Suppl):S257.

3. Lambert L, Xiao Y, Boothroyd L, Segal E, Ross D, Maire S, Kouz S, L’Allier P, Rinfret S,

Vanasse A, Bogaty P. The Introduction of Prehospital ECGs Into a Provincial System of ST-Elevation Myocardial Infarction (STEMI) Care: Impact on Treatment Delays And the Process of Care. CCS 2011; Can J Cardiol 2011;27(Suppl):S62-S63.

4. Lambert L, Ross D, Segal E, Maire S, L’Allier P, Vanasse A, Rinfret S, Kouz S, Bogaty P.

Centers that perform primary percutaneous coronary intervention without on-site cardiac surgery in a system of care of patients with ST-elevation myocardial infarction: Results from a systematic province-wide field evaluation Can J Cardiol 2011;27(Suppl):S61-S62.

5. Lambert L, Brown K, Brophy JM, Roges-Cabau J, Segal E, Bogaty P. Long-Term

outcomes of Patients With ST-Elevation Myocardial Infarction With And Without ReperfusionTherapy: Results from a systematic, province-wide field evaluation in Quebec. Can J Cardiol 2011;27(Suppl):S61.

6. Lambert L, Chakor H, Ross D, Segal E, Xiao Y, Vanasse A, Maire S, Kouz S, Rinfret S,

L'Allier P, Bogaty P. Teasing Out Why Reperfusion Therapy Was Not Given to a Substantial Number of Patients With ST-Elevation Myocardial Infarction (STEMI): A Classification Tool Developed From a Province-Wide Systematic Field Evaluation. Can J Cardiol 2011;27(Suppl):S145.

7. Lambert L, Ross D, Segal E, Maire S, L’Allier P, Vanasse a, Rinfret S, Kouz S, Chakor H,

Bogaty P. Patients With ST-Elevation Myocardial Infarction Sent For Primary Percutaneous Coronary Intervention And Who do Not Receive it: Results From a Systematic Province-Wide Evaluation. Can J Cardiol 2011;27(Suppl):S63.

8. Lambert L, Boothroyd LJ, Xiao Y, Caroll C, Giguere M, Bogaty P. Characteristics of

Practice of Primary Angioplasty Across 13 PCI Centers in Quebec (2008-2009): A Province-Wide Systematic Field Evaluation. Can J Cardiol 2011;27(Suppl):S62.

9. Bogaty P, Xiao Y, Nasmith J, Segal E, Kouz S, Rinfret S, L'Allier P, Ross D, Vanasse A,

Maire S, Lambert L. Under the Radar: Deaths From ST-Elevation Myocardial Infarction That Do Not Appear in Registries. Can J Cardiol 2011;27(Suppl):S63.

10. Lambert L, Xiao Y, L’Allier P, Kouz S, Rinfret S, Ross D, Segal E, Maire S, Vanasse A,

Bogaty P. Characteristics of practice of primary angioplasty in the province of Quebec, Canada (2008-2009): A systematic field evaluation. Circ Cardiovasc Qual Outcomes 2011 in press

11. Lambert L, Xiao Y, Boothroyd L, Segal E, Ross D, Maire S, Kouz S, L’Allier P, Rinfret S, Vanasse A, Bogaty P. The introduction of prehospital ECGs into a provincial system of ST-elevation myocardial infarction (STEMI) care : Impact on treatment delays and the process of care. Circ Cardiovasc Qual Outcomes 2011 in press

Dr Peter Bogaty

Page 9 of 24

12. Doucette K, Brophy JM, Boyer L, Simard S, Dagenais GR, Bogaty P. Can recurrent acute coronary events be predicted by C-reactive protein measurements in the previous six weeks? Can J Cardiol 2010;26 (Suppl D):121D.

13. Brown KA, David K, Lambert LJ, Bogaty P. Reliability of the assessment of patient

comorbidities using Quebec’s medico-administrative data. Can J Cardiol 2010;26 (Suppl D):29D.

14. Lambert LJ, Poliquin S, Brown KA, Moutquin J, Carrier M, Langlois Y, Mathieu P,

Dendukuri N, Morin JE, Guertin J, Bogaty P. A coronary artery bypass graft surgery (CABG) evaluation project : by, for, and with cardiac surgeons. Can J Cardiol 2010;26 (Suppl D):29D.

15. Brown KA, David K, Lambert LJ, Bogaty P. Can Quebec’s hospital inpatient and day

surgery database (Med-Écho) be used to count Percutaneous Coronary Interventions (PCI) In Quebec ? Can J Cardiol 2010;26 (Suppl D):28D.

16. Lambert LJ, Brown KA, Carroll C, Segal E, Ross D, Lefrançois D, Smith W, Maire S,

Giguère M, Guertin JR, Boothroyd L, Bogaty P. Systems of care for ST-elevation myocardial infarction (STEMI) : An evaluation model for the province of Quebec. Can J Cardiol 2010;26 (Suppl D):128D.

17. Lambert L, Carroll-Bilodeau C, Giguere M, Morin J, Boothroyd L, Bogaty P. Portrait of

Treatment of Myocardial Infarction with ST-Elevation (STEMI) in PCI-Capable Hospitals in Quebec, Canada: Mode of Reperfusion and Treatment Delays. Circ Cardiovasc Qual Outcomes 2009;2:e40.

18. Cardinal H, Brophy JM, Bogaty P, Joseph L, Hébert M, Boyer L, Madore F. sFAS improves

diagnostic accuracy for acute coronary syndromes in patients presenting with chest pain. Can J Cardiol 2008;24(Suppl SE):809

19. Lambert L, Carroll-Bilodeau C, Giguere M, Morin J, Boothroyd L, Bogaty P. Portrait of

Thrombolytic Treatment for Myocardial Infarction withST-Elevation (STEMI) in Quebec, Canada: A Province-Wide Field Evaluation. Circ Cardiovasc Qual Outcomes 2009;2:e9

20. Lambert L, Simard S, Carroll-Bilodeau C, Giguere M, Morin J, Boothroyd L, Bogaty P.

Reliability of Process Measures of Care of Patients Presenting with ST-Elevation Myocardial Infarction (STEMI) Abstracted by Hospital Health Record Librarians: Results of a Field Evaluation in Quebec, Canada. Circ Cardiovasc Qual Outcomes 2009;2:e40.

21. Lambert L, Carroll-Bilodeau C, Giguere M, Morin J, Boothroyd L, Bogaty P. Portrait of

Delays for Transfers of Patients With ST-Elevation Myocardial Infarction (STEMI) for Primary PCI in Quebec, Canada : A Step-by-Step Analysis. Circ Cardiovasc Qual Outcomes 2009;2:e40

22. Lambert L, Carroll-Bilodeau C, Giguere M, Morin J, Boothroyd L, Nasmith J, Bogaty P.

Identification of Appropriate Patients for Inclusion in Process Measures of Care of Myocardial Infarction with ST-Elevation (STEMI). Circ Cardiovasc Qual Outcomes 2009;2:e9.

23. St-Germain C, Hanley J, Bogaty P, Boyer L, Engert JC, Brophy JM. Genetic Polymorphism

and the cardiovascular risk of Cyclooxygenase-2 inhibitors. J Am Coll Cardiol 2008;51(Suppl1):A195.

Dr Peter Bogaty

Page 10 of 24

24. Bogaty P, Boyer L, Simard S, Dauwe F, Dupuis R, Verret B, Huynh T, Bertrand F,

Dagenais GR, Brophy JM. Does the pattern of serial values of C-Reactive Protein predict outcome in patiens with acute coronary disease? The RISCA Study. J Am Coll Cardiol 2008;51(Suppl 1):A219.

25. Cardinal H, Madore F, Brophy J, Bogaty P. The Therapeutic Impact of Renal Failure in

Patients who Experience an Acute Coronary Syndrome: Are We Undertreating a Higher-Risk Subset? J Am Soc Nephrol 2007, vol 18, p.584-A.

26. Lambert LJ , Bogaty P, Baillot R, Morin JE, Cartier R, Brophy JM. Coronary artery bypass

surgery and associated mortality in the Quebec elderly, 1993-2004. Can J Cardiol 2007;23(Suppl C):492.

27. Lambert LJ, JM Brophy, JE Morin, P Bogaty. Percutaneous coronary intervention and

associated mortality in the Quebec elderly, 1993-2004. Can J Cardiol 2007;23(Suppl C):115.

28. Noel M, Marcoux A, Boyer L, Simard S, Bertrand F, Bogaty P. Transient increase in blood

inflammatory makers following intense exercise in healthy elderly men. Can J Cardiol 2007;23(Suppl C):795.

29. Côté J, Bertrand O, Rodes-Cabau J, Bogaty P, Champagne J, Brochu B, Miro S, Barbeau

G, Noël B, Poirier P, Despres J, Larose E. Epicardial fat measured during routine cardiovascular magnetic resonnance predicts coronary artery disease. Can J Cardiol 2007;23(Suppl C):893.

30. Larose E, Côté J, Rodes-Cabau J, Bogaty P, Champagne J, Brochu B, Miro S, Noël B,

Poirier P, Bertrand O, Despres J. Epicardial fat measured during routine cardiovascular magnetic resonnance predicts coronary artery disease. J Cardiovasc Magn Res 2007;9(Suppl 1):443.

31. Cardinal H, Brophy J, Bogaty P, Brassard N, Madore F. Do Soluble FAS and Endothelial

Apoptotic Microparticles predict recurrent cardiovascular events in patients with an acute coronary syndrome. Can J Cardiol 2007;23(Suppl C):797.

32. Hachicha Z, Dumesnil JG, Bogaty P, Pibarot P. Low flow, low gradient severe aortic

stenosis despite preserved ejection fraction: a paradoxical patter that is associated with higher LV afterload and increased mortality. Eur Heart J 2007;28(Suppl I):3405.

33. Garceau P, Noël M, Samson M,, Poirier P, Bogaty P. Impact of altitude-induced

hypoxemia on myocardial function in healthy climbers. Can J Cardiol 2007;23(Suppl C):149.

34. Noel M, Cabau JR, Rivest D, Mackey A, Houde C, Cote J, Chetaille P, Delisle G, Bogaty P,

Bertrand OF. The impact of atherosclerotic burden in cryptogenic stroke of young patients with and without paten foramen ovale. Can J Cardiol 2007;23(Suppl C):364.

35. àNoel M, Jobin J, Poirier P, Dagenais G, Bogaty P. Less myocardial ischemia on the

ergocycle than on the treadmill: Is it the exercise protocol or the machine. Can J Cardiol 2007;23(Suppl C):913.

36. Brassard P, Legault S, Garneau C, Bogaty P, JG Dumesnil JG, Poirier P. Aerobic exercise

training reverses diastolic dysfunction uncomplicated well-controlled type 2 diabetes. Diabetes 2007;56(Suppl 1):277A.

Dr Peter Bogaty

Page 11 of 24

37. Bogaty P, Dauwe F, Boyer L, Simard S, Dupuis R, Verret B, Huynh T, Roux R, d'Astous M, Bertrand F, Dagenais GR, Brophy J. Does C-Reactive protein at admission, discharge or one month have incremental clinical value to predict outcome in patients with acute coronary disease. J Am Coll Cardiol 2007; 49(Suppl 1):199A.

38. Hachicha Z, Dumesnil JG, Bogaty P, Pibarot P. Paradoxical low flow, low gradient severe

aortic stenosis despite preserved ejection fraction reflects more severe disease and poorer prognosis: implications for diagnosis and treatment. Circulation 2006;114(Suppl II):II-714.

39. Hachicha Z, Dumesnil JG, Bogaty P, Pibarot P. Paradoxical low flow, low gradient severe

aortic stenosis despite preserved ejection fraction reflects more severe disease and poorer prognosis: implications for diagnosis and treatment. Can J Cardiol 2006;22(Suppl D):218D.

40. Noël M, Jobin J, Marcoux A, Boyer L, Bogaty P. Does sustained ischemic exercise cause

myocardial damage? Circulation 2005;112 :II-811 41. Méthot J, Hamelin BA, Arsenault M, Bogaty P, Plante S, Poirier P. ACE-DD genotype is

associated with endothelial dysfunction in postmenopausal women. Circulation 2005;112 :II-202.

42. Noël M, Jobin J, Poirier P, Dagenais GR, Bogaty P. Does a gradual exercise test ramp

attenuate myocardial ischemia? J Am Coll Cardiol 2005;45(Suppl A):211A-212A . 43. Dagenais GR,Gilbert P, St-Pierre AC, Lamarche B, Després JP, Bogaty P. Long-term

cardiovascular consequences of diabetes among Quebec men, The Quebec Cardiovascular Study. Can J Cardiol 2005;21(Suppl C):222C.

44. Dagenais GR,Gilbert P, St-Pierre AC, Lamarche B, Després JP, Bogaty P. Long-term

disastrous impact of tobacco among Quebec men, The Quebec Cardiovascular Study. Can J Cardiol 2005;21(Suppl C):137C.

45. Bogaty P, Brophy JM, Noël M et al. Impact of prolonged Cyclooxygenase-2 inhibition on

inflammatory markers and endothelial function in patients with ischemic heart disease and raised C-reactive protein: A randomized placebo-controlled study. ACC Current Journal Review 2004 page 13.

46. Méthot J, Hamelin BA, Arsenault M, Bogaty P, Plante S, Poirier P. ACE-DD genotype is

associated with endothelial dysfunction in postmenopausal women. Can J Cardiol 2005;21:113C.

47. Méthot J, Hamelin BA, Bogaty P, Arsenault M, Plante S, Poirier P. Does ACE-DD genotype

play a role on the timing acute coronary events during the menstrual cycle in premenopausal women? Can J Cardiol 2005;21:233C.

48. Noël M, Jobin J, Poirier P, Dagenais GR, Bogaty P. Does a gradual exercise test (RAMP)

attenuate myocardial ischemia? Clin Invest Med 2005;28; 26. 49. Méthot J, Hamelin BA, Arsenault M, Bogaty P, Poirier P. Does renin angiotensin system

genotypes is associated with flow-mediated dilatation of the brachial artery in postmenopausal? Can J Diabetes 2004;28:306.

50. Noël M, Jobin J, Poirier P, Dagenais GR, Bogaty P. L’ischémie myocardique induite à

l’effort: différence marquée entre l’ergocycle et le tapis roulant? Med Sci 2004;20:21. 51. Ferland A, Turbide G, Bogaty P, Jobin J, Larivière MM, Poirier P. Type 2 diabetes and

aerobic exercise – Is prior breakfast deleterious? Med Sci Sports Exerc 2004;36:2281.

Dr Peter Bogaty

Page 12 of 24

52. Pilote B, Bogaty P, Lacourcière Y, Ferland A, Poirier P. Relation entre la tension artérielle

exagérée à l’effort et le monitorage de la tension artérielle chez les diabétiques de type 2. Med Sci 2003;19 (Suppl 1):16.

53. Pilote B, Bogaty P, Ferland A, Lacourcière Y, Poirier P. Association between exaggerated

blood pressure response to exercise and cardiac autonomic nervous system modulation in men with type 2 diabetes free of heart disease. Am J Sports Med 2003;5:182.

54. Méthot J, Hamelin BA, Bogaty P, Arsenault M, Plante S, Poirier P GR. Difference in the

clinical presentation of acute coronary syndrome between premenopausal and postmenopausal women. Circulation 2002;106 (Suppl II):II-540.

55. Méthot J, Hamelin BA, Bogaty P, Aresenault M, Plante S, Poirier P. ACE-DD genotype is

associated with the occurrence of acute Coronary syndrome in postmenopausal women, Can J Cardiol 2002;19 (Suppl A):248A.

56. Méthot J, Poirier P, Bogaty P, Arsenault M, Plante S and Hamelin BA. Does renin

angiotensin polymorphisms in postmenopausal women impact the occurrence of acute coronary syndrome? Can J Cardiol 2002;18 (Suppl B):211B.

57. Pilote B, Bogaty P, Lacourcière Y, Ferland A, Brochu C, Poirier P. Relationship between

exaggerated blood pressure response to exercise and ambulatory blood pressure in patients with type 2 diabetes. Can J Cardiol 2002;18 (Suppl B):213B.

58. Bogaty P, Boyer L, Simard S, Bertrand F, Hamelin B, Dagenais GR. P-Selectin as a

marker of acute coronary artery disease risk independent of C-reactive protein. Circulation 2001;104 (Suppl II):II-636.

59. Bogaty P, Poirier P, Boyer L, Auclair L, Pepin G, Jobin J, Arsenault M. Relation of serial

changes in endothelial function, exercise ischemic parameters, and blood markers in subjects with stable angina undergoing aggressive lipid-lowering: The Can-ADA endothelial dysfunction substudy. Circulation 2001;104 (Suppl II):II-446.

60. Dagenais GR, Auger P, Bogaty P, Bosch J, Gerstein HC, Lonn E, Yi Q, Yusuf S. Impact of

Abdominal Obesity on the Occurrence of Diabetes in Subjects with Ischemic Cardiovascular Disease. Circulation 2001;104 (Suppl II):II-833.

61. Bogaty P, Boyer L, Rousseau L, Arsenault M. Is anteroseptal myocardial infarction an

appropriate term? Circulation 2000;102 (Suppl II):II-793-4. 62. Methot J, Bogaty P, Poirier P, Arsenault M, Pilote S, Plante S, Hamelin BA. The

relationship of the occurrence of acute coronary events in women to the timing of their menstrual cycle. Circulation 2000;102 (Suppl II):II-613.

63. Bogaty P, Poirier P, Boyer L, Auclair L, Jobin J. What induces warm-up angina: exercise or

myocardial ischemia? Circulation 2000;102 (Suppl II):II-522. 64. Bogaty P, Boyer L, Arsenault M. Is the electrocardiographic anteroseptal myocardial

infarction really anteroseptal? Can J Cardiol 2000;16 (Suppl F):157F. 65. Bogaty P, Leiter L, Murray P, Angus C, on behalf of the Can-ADA Study Investigators. The

Can-ADA Study: Do lipid parameters respond differently to atorvastatin therapy in ischemic heart disease subjects with and without type 2 diabetes? Can J Cardiol 2000;16 (Suppl F):234F.

Dr Peter Bogaty

Page 13 of 24

66. Bogaty P, Poirier P, Boyer L, Auclair L, Jobin J. What induces warm-up angina: exercise or myocardial ischemia? Can J Cardiol 2000;16 (Suppl F):192F.

67. Huynh T, Théroux P, Nasmith J, Bogaty P, Solymoss S. Aspirin, warfarin and their

combination in secondary prevention of patients with non-ST elevation coronary syndromes and a prior coronary artery bypass surgery. Can J Cardiol 2000;16 (Suppl F):139F.

68. Baillot P, Bogaty P, Lemieux M, Doyle D, Bauset R, Desaulniers D, Métras J, Perron J,

Raymond G, Cartier P, Brochu H, Simard S. Dissociation between short-term morbidity and mortality in diabetic women undergoing coronary artery bypass. The First International Conference on Women, Heart Disease and Stroke. Victoria, BC, May 7-10, 2000. Can J Cardiol 2000;16 (Suppl B):33B.

69. Bogaty P, Poirier P, Boyer L, Simard S, Bertrand F, Dagenais GR. Is C-reactive protein a

marker for first and recurrent acute coronary events in very different subsets of stable ischemic heart disease? J Am Coll Cardiol 2000;35:313A.

70. Bogaty P, O'Hara GE, Boyer L, Auclair L, Arsenault M, Leblanc MH, Boudreault JR. A

novel non-invasive short hospital stay strategy for patients with low risk myocardial infarction: six month follow-up. J Am Coll Cardiol 2000;35:347A.

71. Poirier P, Garneau C, Bogaty P, Fortin C, Marois L, Phillipon F, Dumesnil JG. Preclinical

diabetic cardiomyopathy: association between asymptomatic left ventricular dysfunction and sub-clinical cardiac autonomic neuropathy in men with type 2 diabetes J Am Coll Cardiol 2000;35:208A.

72. Méthot J, Bogaty P, Poirier P, Arsenault M, Simard J, Plante S, Robitaille NM and Hamelin

BA: Association of polymorphisms in the renin-angiotensin system with acute coronary events in women. Pharmacotherapy 2000;20:1271.

73. Bogaty P, Hamelin B, Charbonneau L, Dion B, Boyer L, Kingma Jr JG. Is adenosine the

mediator of warm-up angina? Circulation 1999;100 (suppl):I-506. 74. Bogaty P, O'Hara GE, Dion B, Auclair L, Boyer L, Arsenault M, Leblanc MH, Boudreault

JR. A short hospital stay strategy for patients with low risk myocardial infarction: six month follow-up. Can J Cardiol 1999;15 (Suppl):135D.

75. Bogaty P, Poirier P, Boyer L, Simard S, Bertrand F, Dagenais GR. Is C-reactive protein a

marker for first and recurrent acute coronary events in stable ischemic heart disease subjects? Can J Cardiol 1999;15 (Suppl):131D.

76. Bogaty P, Hamelin B, Charbonneau L, Dion B, Boyer L, Kingma Jr JG. Is Adenosine the

mediator of warm-up angina. Can J Cardiol 1999;15 (Suppl):224D. 77. Dumont S, Jobin J, Boudreault JR, Dion B, Auclair L, Bélanger J, O'Hara GE, Bogaty P.

Psychological Impact of a Short Stay Strategy for Low Risk Myocardial Infarction Patients. Can J Cardiol 1999;15 (Suppl):225D.

78. Bogaty P, Guimond J, Kingma Jr JG, Robitaille N-M, Charbonneau L, Dagenais GR. The

relation of myocardial perfusion findings to the attenuation of myocardial ischemia observed with repeated exercise. Circulation 1998;98 (suppl):I-708-9.

79. Bogaty P, O’Hara GE, Dion B, Auclair L, Boyer L, Arsenault M, Lebanc M-H, Augustin C-E,

Boudreault J-R. Short hospital stay for uncomplicated myocardial infarction. Circulation 1998;98 (suppl):I-630-1.

Dr Peter Bogaty

Page 14 of 24

80. Bogaty P, Turgeon J, Solymoss S, Poirier P, Boyer L, Simard S, Dagenais GR. Biological

profile in subjects with multiple acute coronary events compared to longstanding stable angina. Circulation 1998;98 (suppl):I-765.

81. Bogaty P, Guimond J, Kingma Jr JG, Charbonneau L, Robitaille N-M, Dagenais GR.

Attenuation of myocardial ischemia with re-exercise: relation to perfusion findings. Can J Cardiol 1998;14 (Suppl F):85F.

82. Bogaty P, O’Hara GE, Dion B, Auclair L, Boyer L, Arsenault M, Augustin E, Boudreault J-R.

Short hospital stay for uncomplicated myocardial infarction. Can J Cardiol 1998;14 (Suppl F):85F.

83. Bogaty P, Turgeon J, Solymoss S, Poirier P, Boyer L, Simard S, Dagenais GR. Biological

profile in subjects with multiple acute coronary events compared to longstanding stable angina. Can J Cardiol 1998 (Suppl F);14:116F.

84. Kingma JG Jr, Plante S, Bogaty P. Blockade of the platelet glycoprotein IIb/IIIa receptor

reduces infarct size in a canine model of myocardial infarction and reperfusion. J Am Coll Cardiol 1998; 31 (suppl A):135A.

85. Hamelin BA, Pham D, Desgagnés V, Rail J, Bogaty P, Morin J, Turgeon J. CYP2D6

ultrarapid metabolism and response to metoprolol. Am Coll Clin Pharm 1997 Annual Meeting.

86. Bogaty P, Theroux P, for the FRSQ Quebec Acute Coronary Care Working Group. Who

dies in the hospital with an acute coronary syndrome? A contemporary profile from the Quebec Acute Coronary Registry. Circulation 1997;96(Suppl):I-261.

87. Bogaty P, Solymoss S, Boyer L, Auger D, Simard S, Rail J, Léveillée J, Turgeon J.

Hemostatic and inflammation profile and angiotensin-converting enzyme (ACE) genotype in subjects with a history of multiple acute coronary events. Can J Cardiol 1997;13(Suppl C):107C.

88. Bogaty P, Theroux P, for the FRSQ Quebec Acute Coronary Care Working Group. A

contemporary profile of who dies in the hospital with an acute coronary syndrome: the Quebec Acute Coronary Registry. Can J Cardiol 1997;13(Suppl C):131C.

89. Solymoss S, Bogaty P, Boyer L, Auger D, Lipman M, Kwan J. Decreasing activated protein

C resistance ratio correlates with known risk markers in subjects with acute and chronic ischemic heart disease. Thromb Haemost 1997;78(Suppl):312.

90. Bogaty P, Robitaille N-M, Boyer L, Auger D, Solymoss S, Turgeon J. Hemostatic and

inflammatory parameters in subjects with previous unheralded myocardial infarction compared to longstanding uncomplicated stable angina. The 4th International Conference on Preventive Cardiology, Montreal, 1997. Can J Cardiol 1997;13 (Suppl B):308B.

91. Bogaty P, Robitaille N-M, Charbonneau L, Plante S, Kingma J. Does glibenclamide block

the attenuation of myocardial ischemia observed with repeated exercise in subjects with ischemic heart disease? Diabetes 1997;46 (Suppl 1):256A.

92. Bogaty P, Plante S, Rossignol G, Plante M, Rouleau JR, Kingma JG Jr. Rapid cardiac

pacing in the presence of a flow-limiting coronary stenosis does not precondition sufficiently to limit infarct size. FASEB 1997;12:279A.

Dr Peter Bogaty

Page 15 of 24

93. Bogaty P, Robitaille N-M, Charbonneau L, Plante S, Kingma JG Jr. Role of ATP-sensitive potassium channels in exercise-induced ischemic preconditioning. Can J Cardiol 1996;12(Suppl E):139E.

94. Bogaty P, Plante S, Rossignol G, Plante M, Rouleau JR, Kingma JG Jr. Effect of demand-

induced myocardial ischemia on infarct size in a novel porcine model. Can J Cardiol 1996;12 (Suppl E):160E.

95. Bogaty P, Robitaille N-M, Plante S, Charbonneau L, Beauchemin J, Kingma JG, Dumesnil

JG. Characterization of exercise-induced ischemic preconditioning and its relation with left ventricular wall motion. Circulation 1995;92 (Suppl):I-736.

96. Bogaty P, Robitaille N-M, Labbé, L, Boyer L, Harnois J, Auger D, Coulombe D, Turgeon J.

Genotype distribution of the angiotensin-converting enzyme insertion/deletion polymorphism (I/D) in unheralded myocardial infarction and uncomplicated chronic stable angina. Can J Cardiol 1995;11 (Suppl E):75E.

97. Murè P, Bogaty P, Dumesnil JG. Immediate echocardiography in acute left heart failure:

implications regarding pathogenetic mechanisms. Can J Cardiol 1995;11 (Suppl E):74E. 98. Marceau D, Duchesneau K, Bogaty P. Risks of the totally implanted central venous

catheter in cancer patients: relation to tumour type. Support Care Cancer 1995;3:372. 99. Bogaty P, Brecker SJ, White SE, Stevenson RN, El-Tamimi H, Balcon R, Maseri A. A

comparison of coronary angiographic findings at acute and chronic first presentation of ischemic heart disease. ACC Curr J Rev 1994;3:9-10.

100. Robitaille NM, Bogaty P, Asselin MJ, Genest M, Labbé L, Lefez C, Turgeon J. Genotype

distribution of the angiotensin converting enzyme insertion/deletion (I/D) polymorphism differs among young cardiac and young healthy Canadian subjects. Circulation 1994;90 (Suppl):I-110.

101. Bogaty P, Guimond J, Rousseau L, Robitaille N-M, Rouleau JR.Angiographic and

scintigraphic correlates of early positivity, ischemic threshold and recovery time in exercise testing in patients with coronary artery disease. Circulation 1994;90 (Suppl):I-329.

102. Robitaille NM, Bogaty P, Asselin MJ, Genest M, Labbé L, Lefez C, Turgeon J. Genotype

distribution of the angiotensin converting enzyme insertion/deletion (I/D) polymorphism differs among young cardiac and young healthy subjects. Can J Cardiol 1994;10 (Suppl C):73C.

103. Bogaty P, Guimond J, Rousseau L, Robitaille NM, Rouleau JR. Does an early positive

exercise test or a prolonged recovery time signify more severe ischemic heart disease ? Can J Cardiol 1994;10 (Suppl C):102C.

104. Marceau D, Bogaty P. The role of the media and public opinion in transforming hospital

policies regarding terminal care. Support Care Cancer 1994;2. 105. Bogaty P, Guimond J, Rousseau L, Rouleau JR. Does more ST segment depression on

the 12 lead exercise electrocardiogram signify more severe ischemic heart disease? Circulation 1993;88 (Suppl):I-22.

106. Bogaty P, Davies G, Hackett D, Crake T, Kooner J, Haider AW, Maseri A. Culprit lesion

and downstream vasoreactivity in unstable angina. Circulation 1993;88 (Suppl):I-609.

Dr Peter Bogaty

Page 16 of 24

107. Bogaty P, Kaski JC, Gavrielides S, Tousoulis D, Rouleau J, Maseri A. Recovery time of ST segment depression correlates with both magnitude of depression at peak exercise and rate-pressure product during recovery. J Am Coll Cardiol 1992;19 (Suppl):96A.

108. Athanassopoulos G, Joshi J, Marsonis A, Bogaty P, Oakley CM, Nihoyannopoulos P.

Significance of delayed recovery following digital exercise echocardiography and temporally related ECG changes. Eur Heart J 1991;12 (suppl):399.

109. Galassi A, Kaski JC, Tousoulis D, Bogaty P, Gavrielides S, Crea F, Maseri A. Patterns of

heart rate during exercise testing and ambulatory electrocardiographic monitoring in patients with Syndrome X. Eur Heart J 1991;12 (suppl):121.

110. Bogaty P, Kaski JC, Gavrielides S, Tousoulis D, Maseri A. Recovery time of ST segment

depression is related to magnitude of depression at peak exercise. Eur Heart J 1991;12 (suppl):329.

111. Bogaty P, Brecker SJ, White SE, El-Tamimi H, Stevenson RN, Balcon R, Maseri A. The

extent of coronary atherosclerosis is very different in unheralded acute myocardial infarction compared to uncomplicated chronic stable angina. Br Heart J 1991;66:57.

112. Bogaty P, Brecker SJ, White SE, El-Tamimi H, Stevenson RN, Balcon R, Maseri A.

Different coronary angiographic findings in unheralded acute myocardial infarction and uncomplicated chronic stable angina. J Am Coll Cardiol 1991;17 (suppl A):254A.

113. Tousoulis D, Kaski JC, Crea F, Gavrielides S, Galassi A, Bogaty P, Maseri A. Reactivity of

proximal and distal angiographically normal and stenotic coronary segments in chronic stable angina. Eur Heart J 1990;11 (suppl):146.

114. Dagenais GR, Bogaty P, Cantin B, Rouleau JR, Dumesnil JG. Does the workload achieved

predict coronary heart events in patients with painless strongly positive exercise test ? Eur Heart J 1988;9 (Suppl I): 345.

115. Bogaty P, Dagenais GR, Cantin B, Rouleau JR. Does the exercise test predict acute

ischemic cardiac morbid events in patients with strongly positive exercise electrocardiogram? Circulation 1988;78 (Suppl II):108.

Submitted Abstracts Lambert LJ, Brown K, Brophy JM, Nasmith J, Segal E, Rodés-Cabau J, Carroll C, Giguère M, Bogaty P. Long-term Outcomes Of Patients With ST-Elevation Myocardial Infarction (STEMI) With And Without Reperfusion Therapy: Results Of A Systematic Province-wide Field Evaluation In Quebec. Circ Cardiovasc Qual Outcomes 2012 Lambert LJ, Boothroyd LJ, Spaziano M, Guertin JR, Rodés-Cabau J, Noiseux N, Nguyen M, Dumont E, Carrier M, de Varennes B, Ibrahim R, Martucci G, Xiao Y, Morin JE, Bogaty P. Where Clinical Practice, Emerging Medical Technology, And Evaluation Intersect In A Healthcare System Based On Equal Access: The Example Of Transcatheter Aortic Valve Replacement. Circ Cardiovasc Qual Outcomes 2012

Dr Peter Bogaty

Page 17 of 24

Lambert LJ, Xiao Y, Kouz S, Rinfret S, Ross D, Segal E, L'Allier Philippe L, Maire S, Vanasse A, Carroll C, Beauchamp C, Giguère M, Bogaty P. The Importance Of Assessing Inter-regional Systems Of Healthcare In Patients With ST-Elevation Myocardial Infarction (STEMI): Examples From A Systematic Field Evaluation. Circ Cardiovasc Qual Outcomes 2012 Sas G, Boothroyd LJ, Morin JE, Moutquin J-M, Lepanto L, Bogaty P, Lambert LJ. Left ventricular assist device type HeartMate II as destination therapy for adult patients with end-stage heart failure: a systematic review of clinical effectiveness. 9th HTAi Annual Meeting Bilbao 2012

Invited Speaker Activities Invited speaker at the McGill Centre for Continuing Education. Atrial Fibrillation. Jewish General Hospital, Montreal, May 12, 2011 Invited professor, speaker at Cardiology Programm of the university of Montreal ST Elevation myocardial: thrombolysis. Hôpital du Sacré-Coeur, Montreal April 12, 2011 Invited speaker, importance of common data definitions at the Institut national d’excellence en santé et en services sociaux (INESSS). The Canadian Cardiovascular Data Definitions and Quality Indicators Project, Toronto 11 mars 2011 Invited speaker at the Table des directeurs médicaux régionaux des services préhospitaliers d'urgence. Résultats des analyses concernant la prise en charge des infarctus du myocarde avec élévation du segment STVille LaSalle 16 février 2011 A systematic province-wide field evaluation STEMI care. Colloque du département d'épidémiologie de l'université McGill. Montréal 27 janvier 2011 Invited expert at the meeting of Urgences Santé. ETIAMEST II : les aspects préhospitaliers. Montréal 10 nov 2010 Invited expert at the CCORT Annual National Meeting. Toronto May 3-4 2010 Chair scientific session at the Vascular Protection Forum 2010. Toronto, June 4-5 2010 Invited speaker at the Quebec Society of Vascular Sciences. Continuing Health Education Program, afternoon symposium Lipids 2010. The usefulness of high sensitivity C-Reactive Protein in the evaluation of CV risk. Montreal, January 15th, 2010. Invited speaker at McGill University Health Centre, division of Clinical Epidemiology Seminar Series. Field Evaluation of Myocardial Infarction with ST-Elevation in Quebec. Montreal, October 29, 2009 Bogaty P, Lambert L, Bilodeau C. RQCT, table de concertation annuelle. Trois-Rivières, June 7, 2009. Bogaty Peter. Debate at the Vascular Protection Forum: CRP should be part of the risk assessment of our patients. Toronto, May 30, 2009.

Dr Peter Bogaty

Page 18 of 24

Lambert L, Bilodeau C, Bogaty P. Results STEMI Field Evalutation Study (ETIAMEST: étude terrain sur l’infarctus aigu du myocarde avec élévation du segment ST), videoconference, Montréal, 19-Mar-09, Abitibi Lambert L, Bilodeau C, Bogaty P. Results STEMI Field Evalutation Study (ETIAMEST: étude terrain sur l’infarctus aigu du myocarde avec élévation du segment ST), Beauce, 26-Feb-09, Chaudière-Appalaches Lambert L, Bilodeau C, Bogaty P. Results STEMI Field Evalutation Study (ETIAMEST: étude terrain sur l’infarctus aigu du myocarde avec élévation du segment ST), Hull, 3-Feb-09, Outaouais Agency (Hull) Invited speaker at St-Michael’s Cardiac Research Rounds. « Atherosclerosis, Inflammation and Biomarkers: What is the Fit? » Toronto, Ontario, January 26, 2009 Invited speaker at St-Michael’s Cardiac Grand Rounds. « To CRP or not to CRP ». Toronto, Ontario, January 26, 2009 Lambert L, Bilodeau C, Bogaty P. Results STEMI Field Evalutation Study (ETIAMEST: étude terrain sur l’infarctus aigu du myocarde avec élévation du segment ST), Montréal, 22-Jan-09, Montréal region Lambert L, Bilodeau C, Bogaty P. Results STEMI Field Evalutation Study (ETIAMEST: étude terrain sur l’infarctus aigu du myocarde avec élévation du segment ST), visioconference, Montréal,15-Jan-09, Lac St-Jean Lambert L, Bilodeau C, Bogaty P. Results STEMI Field Evalutation Study (ETIAMEST: étude terrain sur l’infarctus aigu du myocarde avec élévation du segment ST), Montréal, 15-Jan-09: Presentation at the Montreal Heart Institute Lambert L, Giguère M, Bilodeau C, Bogaty P. Results STEMI Field Evalutation Study (ETIAMEST: étude terrain sur l’infarctus aigu du myocarde avec élévation du segment ST), 16-Dec-08, Laval Lambert L, Giguère M, Bilodeau C, Bogaty P. Results STEMI Field Evalutation Study (ETIAMEST: étude terrain sur l’infarctus aigu du myocarde avec élévation du segment ST), Québec, 15-Dec-08, Québec region Lambert L, Giguère M, Bilodeau C, Bogaty P. Results STEMI Field Evalutation Study (ETIAMEST: étude terrain sur l’infarctus aigu du myocarde avec élévation du segment ST), Trois-Rivières, 9-Dec-08, Mauricie/Quebec centre region Lambert L, Giguère M, Bilodeau C, Bogaty P. Results STEMI Field Evalutation Study (ETIAMEST: étude terrain sur l’infarctus aigu du myocarde avec élévation du segment ST), videoconference, Montréal, 28-Nov-08, Bas St-Laurent region Lambert L, Giguère M, Bilodeau C, Bogaty P. Results STEMI Field Evalutation Study (ETIAMEST: étude terrain sur l’infarctus aigu du myocarde avec élévation du segment ST), Longueuil, 20-Nov-08, Montérégie region Lambert L, Giguère M, Bilodeau C, Bogaty P. Results STEMI Field Evalutation Study (ETIAMEST: étude terrain sur l’infarctus aigu du myocarde avec élévation du segment ST), Montréal, 3-Nov-08: Tertiary Cardiology and RUIS

Dr Peter Bogaty

Page 19 of 24

Lambert L, Giguère M, Bilodeau C, Bogaty P. Results STEMI Field Evalutation Study (ETIAMEST: étude terrain sur l’infarctus aigu du myocarde avec élévation du segment ST), Montréal,10-Oct-08: Presentation to the DSPs Lambert L, Giguère M, Bilodeau C, Bogaty P . RResults STEMI Field Evalutation Study (ETIAMEST: étude terrain sur l’infarctus aigu du myocarde avec élévation du segment ST), Québec, 9-Oct-08: Presentation at DRAMU (Directeur Régional des Affaires Médicales et Universitaires). Lambert L, Giguère M, Bilodeau C, Bogaty P. Results STEMI Field Evalutation Study (ETIAMEST: étude terrain sur l’infarctus aigu du myocarde avec élévation du segment ST), Drummondville, 6-Oct-08: Presentation at Réseau Québecois de cardiologie tertiaire (RQCT). Lambert L, Giguère M, Bilodeau C, Bogaty P. Results STEMI Field Evalutation Study (ETIAMEST: étude terrain sur l’infarctus aigu du myocarde avec élévation du segment ST), Montréal, 2-Oct-08; Presentation at the RUIS Lambert L, Giguère M, Bilodeau C, Bogaty P. Results STEMI Field Evalutation Study (ETIAMEST: étude terrain sur l’infarctus aigu du myocarde avec élévation du segment ST), Québec,10-Sep-08: Presentation at Ministère de la Santé et Services Sociaux (MSSS). Lambert L, Giguère M, Bilodeau C, Bogaty P. HTAi, Montréal, Jul-08, HTAi convention Lambert L, Giguère M, Bilodeau C, Bogaty P. Preliminary Results STEMI Field Evalutation Study (ETIAMEST: étude terrain sur l’infarctus aigu du myocarde avec élévation du segment ST), Québec, 5-Jun-08: Presentation at Ministère de la Santé et Services Sociaux (MSSS). Presentation of a Workshop in Coronary Artery Disease Management at the Vascular Protection Forum, Toronto, May 31, 2008. Invited speaker at the Scientific Committee of the Quebec Tertiary Cardiology Network ( RQCT): STEMI Field Evalutation (ETIAMEST). Montréal, September 25, 2007 Invited speaker at the Scientific Committee of the Quebec Tertiary Cardiology Network ( RQCT): Coronary angioplasty in hospitals with and without cardiac surgery. Montréal, September 25, 2007 Invited speaker at the Scientific Committee of the Quebec Tertiary Cardiology Network ( RQCT): Coronary revascularisation in aged patients in Québec. Montréal, November 20, 2007 Invited speaker at the Agence d'évaluation des technologies et des modes d'intervention en santé. AETMIS. Coronary angioplasty in hospitals with and without cardiac surgery. Presentation to hospital directors (directeurs des services professionnels), Montréal, September, 2007 Participation at a meeting for a project of collaboration between l'INSPQ (Institut national de santé publique au Québec)e t l'AETMIS for the validation of Quebec hospital medico-administrative databases to establish monitoring and evaluation in cardiology. Agence d'évaluations des technologies et des modes d'intervention en santé. AETMIS, Montreal, July 27, 2007 Participation at the CIHR cardiac waiting times meeting,Ottawa, Ontario, July9, 2007 RQCT annual meeting presentation of AETMIS Cardiac Evaluation Unit activities. Montréal,19

Dr Peter Bogaty

Page 20 of 24

juin 2007 Participation at the « Vascular Protection Forum » - - Prevention of vascular, renal, and metabolic abnormalities: Implications of the renin angiotensin aldosterone system. Toronto, Ontario, June 9, 2007 Invited speaker at the medicine department: 'Le traitement de l'infarctus du myocarde avec élévation du segment ST'. Ste-Agathe des Monts Hospital, April 17, 2007 Invited speaker at the Epidemiology department: In quest of the holy grail: Prediction in coronary artery disease. Royal Victoria Hospital, McGill University Health Center, March 8, 2007 Invited speaker at the medicine department: 'Le traitement de l'infarctus avec élévation du segment ST relève-t-il idéalement de la cardiologie tertiaire? Drummondville, January 16, 2007 Invited speaker at the emergency and medicine department : l’infarctus du myocarde avec élévation du segment ST : Est-ce que le traitement idéal relève de la cardiologie tertiaire? Hôtel-Dieu de Sorel, Boucherville, November 28, 2006 Invited speaker at the emergency and medicine department of Hôtel-Dieu d’Arthabaska : l’infarctus du myocarde avec élévation du segment ST : Est-ce que le traitement idéal relève de la cardiologie tertiaire? Hôtel-Dieu d’Arthabaska, Victoriaville, October 16, 2006 Invited speaker at the Consultation Round Table of the RQCT (Réseau québécois de cardiologie tertiaire): Résultats de l’étude sur la revascularisation chez les personnes âgées de plus de 80 ans. June 20, 2006 Invited speaker at the Consultation Round Table of the RQCT (Réseau québécois de cardiologie tertiaire): Avis sur l’efficacité et l’efficience de la thrombolyse et de l’angioplastie primaire dans le traitement de l’infarctus aigu du myocarde avec élévation du Segment ST. June 20, 2006 Invited speaker at the Consultation Round Table of the RQCT (Réseau québécois de cardiologie tertiaire): Évaluation-terrain du traitement de l’infarctus du myocarde avec élévation du Segment ST. June 20, 2006 Invited speaker at the cardiology department of McGill University Health Centre; Montreal General Hospital: Acute ST-Elevation Myocardial Infarction (STEMI): Is PCI for all ideal? May 10, 2006 Invited speaker at the 2005 annual meeting and Symposium of the Canadian Association of Cardiac : Issues in Cardiac Rehabilitation & Prevention; Training above the ischemic threshold / A World to Know Better. CCS Montreal, October 23, 2005 Invited speaker to the symposium Advances in cardiology : CRP-Targeted Therapy Offers a Marginal Advantage over Aggressive LDL Reduction. CCS Montreal, October 22, 2005 Discussant at a Roundtable at the 14th Interventional Cardiology Symposium on thrombolysis and PCI, Montreal (Montreal Heart Institute) June 18, 2005. Invited Speaker to the 14th Interventional Cardiology Symposium : Acute Myocardial Infarction Reperfusion Strategies (STEMI Guidelines) : A case for Thrombolysis, Montreal (Montreal Heart Institute) June 18, 2005. Invited Speaker to the 10th Annual Atlantic Canada Cardiovascuar Conference : Evidence,

Dr Peter Bogaty

Page 21 of 24

Guidelines and Common Sense, Dalhousie University Faculty of Medicine Halifax April 15-16, 2005 Invited Speaker to the 10th Annual Atlantic Canada Cardiovascuar Conference : Acute Management : Direct Intervention of Thrombolysis ; Management of Acute STEMI in 2005, Dalhousie University Faculty of Medicine Halifax April 15-16, 2005 Invited Speaker at a meeting organized by the emergency physicians of the Centre hospitalier du Haut-Richelieu on the contemporary treatment of acute myocardial infarction March 31, 2005 Invited Speaker at the Grand Rounds of the department of medicine of Charles LeMoyne Hospital : Treatment of ST elevation Myocardial Infarction; what is the evidence for the best treatment. Montreal March 24, 2005 Presenter at the Eastern Regional Atorvastatin Consultancy Committee Meeting (PROVE-IT; Opposing Viewpoint) Montreal February 9, 2005 Invited Speaker at JANUS VIII: Optimizing Current Pharmacotherapy in ST Elevation Myocardial Infarction, Whistler January 21, 2005 Invited Speaker for emergency and cardiology department of Hôtel-Dieu de Québec Hospital; Le traitement de l’infarctus aigu du myocarde en 2005 suite aux recommandations de l’AHA/ACC/CCS, Quebec, January 18, 2005 Invited Speaker for the internists at Centre Hospitalier Régional du Grand-Portage: Le traitement de l’infarctus aigu du myocarde en 2005 suite aux recommandations de l’AHA/ACC/CCS, Rivière-du-Loup, December 15, 2004 Invited Speaker at the annual meeting of the cardiology department, Centre Hospitalier de l’Université de Montréal (CHUM); Le traitement de l’infarctus aigu du myocarde en 2005 suite aux recommandations de l’AHA/ACC/CCS, Un débat scientifique. Montreal, Vogue Hotel, November 20, 2004 Invited Speaker for Canadian Working Group of the Canadian Cardiovascular Society: Choosing Reperfusion Therapy / Convalescent Evaluation, Calgary October 25, 2004 Invited Speaker at the emergency and cardiology department, Saint-François d’Assise Hospital; Infarctus du myocarde avec élévation ST: thrombolyse et angioplastie primaire, Quebec, October 21, 2004 Invited Speaker at the 6th National Atherosclerosis Forum; Fluctuating Inflammatory Markers in Patients With Stable Ischemic Heart Disease, Toronto, September 2004 Invited Speaker at the Canadian Cardiovascular Society, Meet-the-Expert-session, Calgary Workshop Proposal: Biomarkers in the Management of Acute Coronary Syndromes, October 25, 2004 Invited Speaker at the Canadian Cardiovascular Society, Meet-the-Expert-session, Calgary Workshop: Introducing the Canadian Working Group Adaptation of the AHA/ACC 2005 Guidelines on the Management of ST Elevation Myocardial Infarction, October 25, 2004 Invited speaker at JANUS VII, Contemporary Cardiovascular Medicine with a View to the Future, Aging in the Cardiovascular System: Physiologic Change or Pathophysiologic Inevitability?

Dr Peter Bogaty

Page 22 of 24

Jamaîca, January 18, 2004. Invited speaker at the Ground Rounds, Montreal Heart Institute: Inflammation et maladie coronarienne : promesse et problématique, October 2, 2003 Invited speaker at the 5th annual convention of the « National Atherosclerosis Forum » Halifax, September 19-21 2003 Invited speaker at Laval University for the presentation of project for the creation of a center on the prevention of cardiovascular disease , Université Laval, May 5, 2003 animation of a ‘Brunch’ for the Quebec Heart Insitute at the PPMC of Laval Hospital, december 1, 2002 (Theme: Prevention in cardiovascular heart disease) Invited speaker at a scientific conference at l’INSERM in Paris, for the FRSQ : Maladie coronarienne et inflammation, November 6, 2002 Organisation and animation of the 'Retraite de l’Institut de cardiologie de Québec', Lac Delage Manor, Quebec, November 2, 2002 President of a session at the 29th International Convention of Electrocardiology on cardiac monitoring and Acute Coronary Heart Syndrome ,Montreal, July 4, 2002 Presentation au Colloque annuel de formation médicale de l'Association des médecins omnipraticiens de Québec, 26 avril, 2002 à Québec sur 'Les nouveaux facteurs de risque de la maladie coronarienne" Invited speaker of a session for the cardiologist association of Quebec regional scientific conference : "Les nouveaux facteurs de risque de la maladie coronarienne" Atelier scientifique régional, Mont Sainte-Anne, January 27, 2002; Protagoniste à un débat à la Société canadienne de cardiologie, congrès 2001 à Halifax (22 octobre) au Symposium Satellite: La prise en charge des patients présentant un risque accru d'événements cardiovasculaires: les véritables débats. Sujet: Devrions-nous être plus sélectifs lorsque nous prescrivons des "pilules" éprouvées pour la prévention secondaire? Président d’un colloque ('La prescription d'exercice: considérations spéciales') au 2e Symposium international de Québec sur la réadaptation cardio-respiratoire 6-8 juin, 2001 Presentation à l’Atelier régional scientifique de l’Association des cardiologues du Québec sur « Les inhibiteurs des récepteurs IIb/IIIa plaquettaires », le 20 septembre 2000 Invited speaker National Atherosclerosis Forum: Results of the Can-ADA substudy on endothelial function. Montréal ) 22-24 septembre, 2000 Invited speaker at the symposium "Acute Coronary Syndromes: Searching for Innovative Solutions" (HealthCare Communications - Schering Canada Inc.), Hockley Valley Resort (Ontario), May 12-14, 2000 Invited speaker at the Grand Rounds, Quebec Heart Institute: A case of Acute Coronary Syndrome. April 27, 2000 Presentation au professeur A. Murad, prix Nobel de la médecine, à l’Hôpital Laval 23 avril 2000.

Dr Peter Bogaty

Page 23 of 24

Inflammation et maladie coronarienne Présentation aux médecins de l'urgence de l'Hôpital Laval sur la thrombolyse dans l'infarctus aigu, le 31 mars, 2000 Conférencier pour l’étude Can-ADA et la sous-étude sur la fonction endothéliale lors du Canadian Atorvastatin Research Roundtable (CARR), New York, 11-13 février, 2000 Grand Rounds de l’Institut de cardiologie de Québec 22 septembre 1999, Un cas d’angine post-infarctus Présentation à la journée de la recherche, Faculté de médecine, Université Laval, 25 mai, 1999, L'adénosine est-elle le médiateur impliqué dans l'atténuation de l'ischémie myocardique observée après un exercice de réchauffement? Présentation sur ‘Le retour au travail post-infarctus’ le 25 avril, 1998 à l’Université Laval aux omnipraticiens dans le cadre du 7ième Colloque annuel de médecine du travail et de l’environnement du CLSC Haute-Ville Présentation au personnel du centre de recherche de l’hôpital Laval sur l’interprétation de l’ECG, 7 décembre 1997 Présentation à St John’s, Terre Neuve au Memorial University, Grand Rounds de médecine, L’angine instable: nouvelles données sur la pathogénèse et la thérapeutique, 5 décembre 1997 Présentation à la réunion de recherche en cardiologie 22 octobre, 1997, Nouvelles données: une dichotomie entre la maladie coronarienne aigue et la maladie coronarienne chronique Président d’une séance à la 4ième Conférence internationale de cardiologie préventive, Montréal, 30 juin, 1997, L’approche clinique du patient avec cardiopathie ischémique ou accident vasculaire cérébral Conférence conjointe de médecine de l’hôpital Laval, Nouveautés en réanimation cardio-respiratoires: nouveaux algorithmes d’intervention, 14 janvier, 1997 Présentation au personnel du centre de recherche a l’hôpital Laval, La cardiopathie ischémique les 19 et 26 novembre, 1996 Présentation au congrès de l’Association québécoise des infirmières et infirmiers en recherche clinique. Le rôle des plaquettes et de la coagulation dans les syndromes coronariens aigus, 18 octobre 1996 Accueil du Dr Lance Gould et du Dr Fréderic Sax pour présentations à la Société de cardiologie de Québec et à la réunion de recherche de l’Institut de cardiologie de Québec, 23-24 septembre et 30 septembre-1er octobre, 1996 Invited speadker at the Grand Rounds of the Jewish General Hospital, Montreal, April 29, 1996. Unstable Angina: Update and Overview” Invited speaker at the research ground rounds of the Quebec Heart Institute, L’unité coronarienne informatisée, March 20, 1996 President of a symposium, Le continuum de l’angine: nouvelles perspectives sur les mécanismes

Dr Peter Bogaty

Page 24 of 24

sous-jacents, Quebec (Château Frontenac), November 24-26, 1995 Invited speaker for the family physicians: La maladie coronarienne: concepts et prévention. Beaupré, Quebec June 13,1995 Invited speaker for the "clinician point of view" at, Méga-études symposium, recommandations provinciales et pharmaco-économie: leur impact sur la pratique médicale at the Ritz Carlton, Montreal, June 9,1995 Invited speaker at the Quebec cardiologist association convention de l'Association, debate protagonist-antagonist, Le meilleur traitement de l'angine instable: pharmacologique vs mécanique, Chicoutimi. Quebec June 1, 1995 Invited speaker at a panel-discussion, Angina Continuum Roundtable Meeting (Healthlink Communications) at the American College of Cardiology session meeting. New-Orleans, March 18, 1995 Invited speaker at the Royal Victoria Hospital: Cardiology Research Rounds, Stratification de risque post syndrome coronarien aigu: nouvelles perspectives et proposition pour une étude clinique. Montreal, January 23, 1995 Invited speaker at the cardiology department of Hôtel Dieu de Lévis , Quebec: presentation of the DOMASCA Study. December 10. 1994 Invited speaker at the medicine interdepartmental meeting, Hôpital St-François d’Assise: Les béta-bloqueurs post-infarctus. Quebec April 3, 1994 Invited speaker at the emergency department of Laval Hospital: Introduction to the GUSTO II Study. March 25, 1994 Invited speaker at the cardiology department of Hôpital de l’Enfant-Jésus, Quebec: presentation of the DOMASCA Study. March 9,1994 Invited speaker at the Grand Rounds’, Hôpital St-François d’Assise, Quebec on thrombolysis. March 2, 1994